Carcinoma in situ

From WikiMD's Medical Encyclopedia

Revision as of 16:41, 5 March 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Carcinoma in situ (CIS) is a term used in medicine to describe a group of abnormal cells. While these cells have the potential to become cancer, they are not yet invasive and therefore are not considered a true cancer. Instead, they are often referred to as pre-cancerous lesions.

Definition

Carcinoma in situ is defined as a group of abnormal cells that are confined to their place of origin. These cells have not yet invaded the basement membrane or other tissues. The term "in situ" is Latin for "in its original place".

Types

There are several types of carcinoma in situ, each named for the type of cells involved and the location in the body where they are found. These include:

Diagnosis

Carcinoma in situ is often diagnosed through routine screening tests, such as a Pap smear for cervical intraepithelial neoplasia or a mammogram for ductal carcinoma in situ. If these tests detect abnormal cells, further testing may be done to confirm the diagnosis.

Treatment

The treatment for carcinoma in situ depends on the type and location of the abnormal cells. Options may include close monitoring, surgery to remove the abnormal cells, or treatment with radiation or drugs to destroy the cells.

Prognosis

The prognosis for carcinoma in situ is generally good, as these cells have not yet become invasive. However, if left untreated, they may develop into invasive cancer.

See also

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!




Stub icon
   This article is a oncology stub. You can help WikiMD by expanding it!




Stub icon
   This article is a  stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.